---
title: "Park Medi World Ltd (PARKHOSPS) — Share Price, Financials & Analysis"
symbol: "PARKHOSPS"
company: "Park Medi World Ltd"
canonical: "https://tapetide.com/stocks/PARKHOSPS"
isin: "INE119201023"
nse_symbol: "PARKHOSPS"
bse_code: "544645"
sector: "Healthcare Services"
industry: "Hospitals"
market_cap_cr: 12027.11
generated_at: "2026-09-13T18:26:04.343Z"
---

# Park Medi World Ltd (PARKHOSPS)

Canonical page: https://tapetide.com/stocks/PARKHOSPS

## Company

- **NSE Symbol:** PARKHOSPS
- **BSE Code:** 544645
- **ISIN:** INE119201023
- **Sector:** Healthcare Services
- **Industry:** Hospitals
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Listed Since:** 2025-12-17
- **Face Value:** ₹2
- **F&O Eligible:** No
- **Website:** parkhospital.in

## About

Park Medi World engaged in the business of, inter alia, establishing, maintaining and running hospitals, nursing homes, clinics, dispensaries, maternity homes, child welfare, family planning etc.(Source : 202503 Annual Report Page No:320)

## Latest Price

- **Price:** ₹279.3
- **Change:** -1.5 (-0.53%)
- **Open:** ₹279
- **Day High:** ₹281.7
- **Day Low:** ₹276.65
- **Previous Close:** ₹280.8
- **Volume:** 211652
- **As Of:** 2026-09-11T10:27:49+00:00

## Key Fundamentals

Observed at 2026-09-11T04:34:37.936099Z.

- **Market Cap:** ₹12027.11 Cr
- **Classification:** Microcap
- **P/E (reported):** 40.9
- **P/E (TTM):** 42.13
- **EPS (TTM):** ₹6.63
- **Book Value:** ₹46.54
- **Price to Book:** 6.03
- **Dividend Yield:** 0%
- **ROE:** 13%
- **ROCE:** 18.1%
- **Debt to Equity:** 0.18
- **Revenue (yearly):** ₹1711 Cr
- **Net Income:** ₹273.6 Cr
- **EBITDA:** ₹475.9 Cr
- **52-Week High:** ₹305
- **52-Week Low:** ₹138.1
- **RSI (14):** 47.6

## Key Insights

### Strengths

- Company has reduced debt.

### Weaknesses

- Though the company is reporting repeated profits, it is not paying out dividend

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | 52.8% | -10.28% | 111.96% |
| ebitda margin growth | -0.89% | -1.66% | 2.66% | -13.84% |
| net income growth | 15.36% | 27.02% | 5% | 11% |
| revenue growth | 3.31% | 19.99% | 10% | 17% |
| roce | -2.11% | -17.35% | -13.06% | 25.76% |
| roe | 15.38% | -32.5% | 16.17% | -64.53% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 348 | 354 | 399 | 410 | 410 | 460 | 476 |
| Expenses | 265 | 265 | 294 | 297 | 311 | 333 | 350 |
| Operating Profit | 83 | 88 | 105 | 113 | 99 | 127 | 126 |
| OPM % | 24 | 25 | 26 | 27 | 24 | 28 | 26 |
| Other Income | 15 | 9 | 7 | 8 | 9 | 8 | 8 |
| Interest | 16 | 16 | 15 | 15 | 15 | 14 | 10 |
| Depreciation | 15 | 16 | 15 | 15 | 15 | 18 | 19 |
| Profit before tax | 67 | 66 | 82 | 91 | 78 | 103 | 105 |
| Tax % | 32 | 20 | 20 | 14 | 32 | 26 | 16 |
| Net Profit | 46 | 52 | 66 | 79 | 53 | 77 | 89 |
| EPS in Rs | 2.97 | 1.17 | 1.51 | 1.91 | 1.17 | 1.64 | 1.91 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 766 | 1084 | 1255 | 1231 | 1394 | 1679 | 1756 |
| Expenses | 457 | 740 | 863 | 919 | 1020 | 1233 | 1291 |
| Operating Profit | 309 | 345 | 391 | 312 | 374 | 446 | 466 |
| OPM % | 40 | 32 | 31 | 25 | 27 | 27 | 27 |
| Other Income | 3 | 9 | 15 | 29 | 30 | 32 | 32 |
| Interest | 24 | 40 | 51 | 72 | 62 | 61 | 53 |
| Depreciation | 24 | 35 | 41 | 51 | 57 | 62 | 67 |
| Profit before tax | 265 | 278 | 315 | 218 | 286 | 355 | 378 |
| Tax % | 26 | 28 | 28 | 30 | 25 | 23 | — |
| Net Profit | 187 | 199 | 228 | 152 | 215 | 274 | 297 |
| EPS in Rs | 80.54 | 11.76 | 14.29 | 9.98 | 5.25 | 5.98 | 6.63 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 19 | 77 | 77 | 77 | 77 | 86 |
| Reserves | 256 | 380 | 610 | 806 | 975 | 1936 |
| Borrowings | 292 | 517 | 576 | 687 | 682 | 364 |
| Other Liabilities | 249 | 319 | 331 | 343 | 393 | 411 |
| Total Liabilities | 816 | 1293 | 1593 | 1912 | 2127 | 2797 |
| Fixed Assets | 365 | 458 | 536 | 837 | 890 | 1309 |
| CWIP | 7 | 29 | 5 | 32 | 37 | 123 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 443 | 806 | 1052 | 1043 | 1199 | 1365 |
| Total Assets | 816 | 1293 | 1593 | 1912 | 2127 | 2797 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 223 | 155 | 199 | 367 | 215 | 329 |
| Cash from Investing Activity | -233 | -248 | -234 | -76 | -100 | -316 |
| Cash from Financing Activity | 49 | 163 | 1 | -130 | -89 | 121 |
| Net Cash Flow | 39 | 70 | -34 | 161 | 26 | 134 |
| Free Cash Flow | 86 | 64 | 106 | 299 | 70 | 209 |
| CFO/OP | 96 | 72 | 76 | 150 | 80 | 96 |

### Ratios

| Item | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 151 | 151 | 168 | 151 | 161 | 129 |
| Inventory Days | 47 | 14 | 3 | 3 | 3 | 4 |
| Days Payable | 121 | 101 | 110 | 133 | 176 | 134 |
| Cash Conversion Cycle | 77 | 64 | 61 | 21 | -12 | -2 |
| Working Capital Days | 40 | 60 | 40 | 21 | 30 | 28 |
| ROCE % | — | 38 | 31 | 20 | 20 | 19 |

## Shareholding Pattern

### Quarterly

| Category | Mar 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- |
| Promoters | 99.17% | 82.89% | 82.89% | 82.89% |
| FIIs | 0% | 1.28% | 0.86% | 0.82% |
| DIIs | 0% | 8.58% | 8.95% | 8.95% |
| Government | 0% | 0.2% | 0.3% | 0% |
| Public | 0% | 5.01% | 3.96% | 4.54% |
| Others | 0.83% | 2.04% | 3.04% | 2.79% |
| No. of Shareholders | 7 | 15 | 50863 | 52428 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Sell
- **Buy / Neutral / Sell:** 3 / 8 / 8

### Moving Averages — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 282.78 | Sell |
| EMA (10) | 282.4 | Sell |
| SMA (20) | 281.65 | Sell |
| EMA (20) | 282.68 | Sell |
| SMA (50) | 283.04 | Sell |
| EMA (50) | 280.2 | Sell |
| SMA (100) | 274.12 | Buy |
| EMA (100) | 263.94 | Buy |
| SMA (200) | — | Neutral |
| EMA (200) | — | Neutral |

### Oscillators — summary: **Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 46.01 | Neutral |
| MACD (12,26,9) | -0.12 | Sell |
| Stochastic (14,3,3) | 45.49 | Neutral |
| ADX (14) | 14.22 | Neutral |
| Williams %R (14) | -61.32 | Neutral |
| ATR (14) | 9.1 | High Volatility |
| ROC (12) | -3.42 | Sell |
| Stoch RSI (14) | 12.29 | Buy |
| UO (7,14,28) | 50.21 | Neutral |

## Analyst Ratings

| Recommendation | Analysts | Share |
| --- | --- | --- |
| Buy | 1 | 100% |
| Hold | 0 | 0% |
| Sell | 0 | 0% |

Based on 1 analyst ratings, observed at 2026-09-11T04:34:35.648872+00:00.

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-08 | [Announcement under Regulation 30 (LODR)-Acquisition](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9f0c9f4d-29a1-468b-8b53-685dbcbfc92e.pdf) |
| 2026-09-05 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=289a67f4-4829-47b4-8164-0b07e21565c8.pdf) |
| 2026-09-04 | [Shareholder Meeting / Postal Ballot-Scrutinizer"s Report](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=05229ee2-3e88-4655-9b91-209d0b989b40.pdf) |
| 2026-08-31 | [Board Meeting Outcome for Outcome Of Board Meeting Held On August 31 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0c8417d2-6673-44fb-9584-62091fd86c52.pdf) |
| 2026-08-31 | [Announcement under Regulation 30 (LODR)-Acquisition](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5880258b-5bca-446c-b6a4-d2a30ac6547a.pdf) |
| 2026-08-29 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a5f87ee2-8320-4521-8192-28f492ea4830.pdf) |
| 2026-08-28 | [Notice Of 15Th Annual General Meeting](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6064e883-daad-4c59-a8cf-3f5aefc2e5a7.pdf) |
| 2026-08-28 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=11a42df9-2bae-44b5-9b0d-bb197abc8c4a.pdf) |
| 2026-08-28 | [Intimation Under Regulation 30 Of SEBI (LODR) Regulations 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=eb455e73-ef22-4790-8c3c-db1d970f63d7.pdf) |
| 2026-08-26 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6c33094a-a4b7-4612-aab2-c9fe3960f289.pdf) |

### Earnings Call Transcripts

| Date | Document |
| --- | --- |
| 2026-08-08 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1664cc6e-61af-48c0-be59-26c2c1e2483d.pdf) |
| 2026-05-15 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b425bbfd-766f-4c71-a8f1-157f3a8d76a0.pdf) |
| 2026-02-02 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=121cf1bd-0b0c-4413-91bd-daf91aa0946b.pdf) |

### Earnings Call Recordings

| Date | Document |
| --- | --- |
| 2026-08-04 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f7790add-a468-4154-91c9-dec8e24c69d7.pdf) |
| 2026-05-13 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ac37e763-1fa3-4cd9-afb8-7ae44b20858e.pdf) |
| 2026-01-29 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6e27527d-c574-45ec-8cb4-fedb6b2490cd.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-08-03 | [Standalone And Consolidated Results For The Quarter Ended 30 June 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=15c75b21-fa12-4095-bd7e-a63a0c8630a5.pdf) |
| 2026-05-12 | [Outcome Of Board Meeting Dated May 12 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dc6aaf12-9640-4393-b60f-7de2c5a38bc2.pdf) |
| 2026-01-28 | [Outcome Of The Board Meeting Held On January 28 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=45aa0822-1b69-48e2-bc7c-2bb9dee21751.pdf) |

### Investor Presentations

| Date | Document |
| --- | --- |
| 2026-08-03 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=376f4166-1055-497f-992b-8d27f24a8a32.pdf) |
| 2026-05-12 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4580c8c3-1ff4-4020-8a65-cadb3460e5ef.pdf) |
| 2026-01-28 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=85920ba2-0310-4e9e-8d94-f36bcd975074.pdf) |
| 2026-01-28 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9a123bb2-201c-4cc8-859c-9836d068cd86.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 7 May - Park Medi World to hold Q4 and 12M FY26 earnings call on May 13, 2026 after results. | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 7 May - Park Medi World to hold Q4 and 12M FY26 earnings call on May 13, 2026 after results.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/ebae16ae-faec-4431-9314-c51f783cbe0f.pdf) |
| 7 May - Board meeting on May 12, 2026 to approve audited FY26 standalone and consolidated results. | [Board Meeting Intimation for Intimation Of Board Meeting 7 May - Board meeting on May 12, 2026 to approve audited FY26 standalone and consolidated results.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/80f6ab3c-f071-421f-9c2e-c2c573ffb5b9.pdf) |
| 4 May - Park Medicenters to incorporate wholly owned step-down subsidiary for healthcare services on May 4, 2026. | [Announcement under Regulation 30 (LODR)-Acquisition 4 May - Park Medicenters to incorporate wholly owned step-down subsidiary for healthcare services on May 4, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/28bfb9e7-8954-41e5-a90f-08aaeb1604e5.pdf) |
| 4 May - Park Medicenters to incorporate wholly owned step-down subsidiary for healthcare services on May 4, 2026. | [Announcement under Regulation 30 (LODR)-Acquisition 4 May - Park Medicenters to incorporate wholly owned step-down subsidiary for healthcare services on May 4, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/28bfb9e7-8954-41e5-a90f-08aaeb1604e5.pdf) |
| 27 Mar - Park Medi World: trading window closed Apr 1, 2026 until 48 hours after audited FY2026 results. | [Closure of Trading Window 27 Mar - Park Medi World: trading window closed Apr 1, 2026 until 48 hours after audited FY2026 results.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/123eac77-dca4-405b-8c73-e77a9aacfd43.pdf) |
| 27 Mar - Panchkula hospital launch postponed from March 29, 2026 to April 10, 2026. | [Update On Product Launch 27 Mar - Panchkula hospital launch postponed from March 29, 2026 to April 10, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/02a0391f-6540-4c01-8b0e-4ab725dcc042.pdf) |
| 20 Mar - Completed acquisition of SVPD Healthcare Pvt Ltd on March 20, 2026; now 100% owned by Park Medi World. | [Announcement under Regulation 30 (LODR)-Updates on Acquisition 20 Mar - Completed acquisition of SVPD Healthcare Pvt Ltd on March 20, 2026; now 100% owned by Park Medi World.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/c4cb86d4-a1b7-4b43-84ce-f2e6163c11a3.pdf) |
| 13 Mar - KMMF bought 175,164 shares on March 11, 2026; stake now 5.0393%. | [Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011 13 Mar - KMMF bought 175,164 shares on March 11, 2026; stake now 5.0393%.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/7CB51F9F_8D9A_4A49_8C1E_58E54C0DB453_164216.pdf) |
| 10 Mar - Panchkula hospital opens March 29, 2026; Mohali adds 150 beds costing approx. Rs.40 crore. | [Announcement Under Regulation 30 - SEBI (LODR) Regulations 2015 10 Mar - Panchkula hospital opens March 29, 2026; Mohali adds 150 beds costing approx. Rs.40 crore.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/68ae439e-a24f-49c1-93cf-af4e77a532a1.pdf) |
| 10 Mar - Launch Panchkula hospital from March 29, 2026; Mohali adds 150 beds, Rs.40 crore investment. | [Board Meeting Outcome for Outcome Of Board Meeting: Expansion In Tricity Region: Panchkula & Mohali 10 Mar - Launch Panchkula hospital from March 29, 2026; Mohali adds 150 beds, Rs.40 crore investment.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/eca02932-9bfd-4a18-830b-3c9e2975ada5.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| May 2026 | [Concall - May 2026](https://www.bseindia.com/xml-data/corpfiling/AttachHis/b425bbfd-766f-4c71-a8f1-157f3a8d76a0.pdf) |
| May 2026 | [Concall - May 2026](https://www.bseindia.com/xml-data/corpfiling/AttachLive/b425bbfd-766f-4c71-a8f1-157f3a8d76a0.pdf) |
| May 2026 | [Concall - May 2026](https://www.bseindia.com/xml-data/corpfiling/AttachLive/4580c8c3-1ff4-4020-8a65-cadb3460e5ef.pdf) |
| Feb 2026 | [Concall - Feb 2026](https://www.bseindia.com/xml-data/corpfiling/AttachHis/121cf1bd-0b0c-4413-91bd-daf91aa0946b.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T18:26:04.343Z.